Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0304-3835(03)00105-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!